Neurocrine Bioscienc (NBIX)
93.23 +5.69 (+6.50%) 13:54 ET [NASDAQ]
91.62 x 100 92.33 x 100
Realtime by (Cboe BZX)
91.62 x 100 92.33 x 100
Realtime 87.00 -0.54 (-0.62%) 08:51 ET
for Wed, Apr 9th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NBIX | SMMT | CORT | ||
| Company | Neurocrine Bioscienc | Summit Therapeu ADR | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 85.96 | 16.33 | 69.54 | ||
| High | 92.74 | 18.59 | 73.42 | ||
| Low | 84.23 | 15.78 | 64.62 | ||
| Last | 93.23 | 18.20 | 71.81 | ||
| Change | +5.69 | +1.56 | +1.32 | ||
| % Change | +6.50% | +9.37% | +1.87% | ||
| Volume | 1,126,040 | 1,778,395 | 1,181,428 | ||
| 20-Day Average Volume | 1,358,510 | 2,483,992 | 2,230,031 | ||
| Previous Close | 87.54 | 16.64 | 70.49 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 107.07 | 19.32 | 67.11 | ||
| 20-Day Raw Stochastic | 16.47% | 17.97% | 21.65% | ||
| 20-Day Relative Strength | 26.02% | 41.02% | 50.75% | ||
| Weighted Alpha | -42.13 | -17.61 | +116.27 | ||
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | ||
| Previous Opinion | 100% Sell | 16% Sell | 100% Buy | ||
| Last Month's Opinion | 56% Sell | 8% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.37% since 04/02/25 | -18.60% since 04/02/25 | -19.41% since 04/02/25 | ||
| Low | 84.23 on 04/09/25 | 15.55 on 04/07/25 | 64.62 on 04/09/25 | ||
| High | 107.53 on 04/03/25 | 19.64 on 04/03/25 | 82.96 on 04/03/25 | ||
| 1-Month | |||||
| %Chg | -20.82% since 03/07/25 | -6.33% since 03/07/25 | +21.92% since 03/07/25 | ||
| Low | 84.23 on 04/09/25 | 15.55 on 04/07/25 | 52.95 on 03/10/25 | ||
| High | 116.23 on 03/26/25 | 21.70 on 03/26/25 | 117.33 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -35.48% since 01/08/25 | -11.50% since 01/08/25 | +30.68% since 01/08/25 | ||
| Low | 84.23 on 04/09/25 | 15.55 on 04/07/25 | 49.00 on 01/13/25 | ||
| High | 154.61 on 01/30/25 | 25.00 on 01/24/25 | 117.33 on 03/31/25 | ||
| 6-Month | |||||
| %Chg | -19.82% since 10/09/24 | -11.88% since 10/09/24 | +47.03% since 10/09/24 | ||
| Low | 84.23 on 04/09/25 | 15.55 on 04/07/25 | 42.01 on 10/31/24 | ||
| High | 154.61 on 01/30/25 | 25.00 on 01/24/25 | 117.33 on 03/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,728,089 | 12,274,995 | 7,436,906 | ||
| Shares Outstanding, K | 99,704 | 737,680 | 105,503 | ||
| Annual Sales | 2,355,300,000 | 0 | 675,040,000 | ||
| Annual Net Income | 341,300,000 | -221,320,000 | 141,210,000 | ||
| Last Quarter Sales | 627,700,000 | 0 | 181,890,000 | ||
| Last Quarter Net Income | 103,100,000 | -61,200,000 | 30,750,000 | ||
| 60-Month Beta | 0.33 | -0.46 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.00 on 02/06/25 | -0.08 on 02/24/25 | 0.26 on 02/26/25 | ||
| Latest Earnings Date | 05/07/25 | 05/07/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 28.34 | 0.00 | 60.20 | ||